Kauczor Hans-Ulrich, Zechmann Christian, Stieltjes Bram, Weber Marc-Andre
Department of Radiology, Innovative Cancer Diagnostics and Therapy, German Cancer Research Center, Heidelberg, Germany.
Cancer Imaging. 2006 Jun 1;6(1):51-5. doi: 10.1102/1470-7330.2006.0010.
Morphology as demonstrated by CT is the basis for radiotherapy planning. Intensity-modulated and adaptive radiotherapy techniques would greatly benefit from additional functional information allowing for definition of the biological target volume. MRI techniques include several which can characterize and quantify different tissue properties and their tumour-related changes. Results of perfusion MRI represent microvascular density and permeability; MR spectroscopy depicts particular metabolites; diffusion weighted imaging shows tissue at risk and tumour cellularity; while dynamic 3D acquisition (4D MRI) shows organ motion and the mobility of tumours within them.
CT所显示的形态学是放射治疗计划的基础。调强放疗和自适应放疗技术将从额外的功能信息中大大受益,这些信息有助于定义生物靶区。MRI技术包括几种能够表征和量化不同组织特性及其与肿瘤相关变化的技术。灌注MRI的结果代表微血管密度和通透性;磁共振波谱描绘特定的代谢物;扩散加权成像显示危险组织和肿瘤细胞密度;而动态三维采集(四维MRI)显示器官运动以及其中肿瘤的移动性。